Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,697 | 3,073 | 5,686 | 7,868 | 56 |
| Receivables | 64 | 51 | 91 | 99 | 32 |
| TOTAL | $1,833 | $3,125 | $5,777 | $7,967 | $88 |
| Non-Current Assets | |||||
| PPE Net | 1,580 | 33 | N/A | N/A | N/A |
| Investments And Advances | 350 | 358 | 537 | N/A | N/A |
| Intangibles | 32,026 | N/A | N/A | N/A | N/A |
| TOTAL | $33,956 | $391 | $537 | $0 | $0 |
| Total Assets | $35,789 | $3,515 | $6,314 | $7,967 | $88 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 559 | 407 | 99 | 71 | N/A |
| Other current liabilities | 50 | N/A | N/A | N/A | N/A |
| TOTAL | $670 | $407 | $99 | $71 | $290 |
| Non-Current Liabilities | |||||
| TOTAL | $571 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,242 | $407 | $99 | $71 | $290 |
| Shareholders' Equity | |||||
| Common Shares | 26,076 | 13,823 | 13,823 | 13,803 | 16,308 |
| Retained earnings | -18,700 | -11,680 | -8,112 | -6,382 | -16,510 |
| Other shareholders' equity | 27,171 | 965 | 503 | 475 | 0 |
| TOTAL | $34,547 | $3,108 | $6,214 | $7,897 | $-203 |
| Total Liabilities And Equity | $35,789 | $3,515 | $6,314 | $7,967 | $88 |